国药股份：2025年第二次临时股东大会决议公告

Core Viewpoint - The announcement from China National Pharmaceutical Group Co., Ltd. (国药股份) indicates the approval of significant corporate governance changes during the second extraordinary general meeting of shareholders for 2025, specifically the cancellation of the supervisory board and the revision of related proposals [2] Group 1 - The second extraordinary general meeting of shareholders for 2025 was held on August 19, 2025 [2] - The proposal to cancel the supervisory board was approved during the meeting [2] - The meeting also included discussions on amendments to related governance documents [2]